October 15, 2025- B. Braun Medical Inc. announced the launch of Midazolam in 0.8% Sodium Chloride Injection in the U.S. market. The preservative-free injections will be offered in two strengths — 50 mg in 50 mL and 100 mg in 100 mL. Both strengths are packaged in IV bags that are not made with DEHP, PVC or natural rubber latex, placing a priority on patient and environmental safety.
The Midazolam in 0.8% Sodium Chloride Injections has a 36-month shelf life, providing healthcare facilities with greater flexibility in inventory management and long-term storage. In addition, each bag incorporates a 2D enhanced barcode that includes the National Drug Code (NDC) number, lot number and expiration date. These updates are part of B. Braun’s ongoing commitment to making workflows safer and more efficient for clinicians—while helping reduce the likelihood of medication errors.
With the release of Midazolam in 0.8% Sodium Chloride Injection, B. Braun continues to expand its portfolio of essential injectable medications, reinforcing its role as a trusted partner in advancing healthcare safety and reliability.
For additional information, please see full Prescribing Information.
Continue Reading from B.Braun Medical Inc.